Jaideep Behari MD
Hepatology & Liver Transplantation
Associate Professor, Medicine, University of Pittsburgh School of Medicine
Join to View Full Profile
200 Lothrop StreetPittsburgh, PA 15213
Phone+1 412-647-3087
Dr. Behari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Gastroenterology, 2003 - 2006- UPMC Medical EducationResidency, Internal Medicine, 2002 - 2003
UMass Chan Medical SchoolResidency, Internal Medicine, 2000 - 2002
Sawai Man Singh Medical CollegeClass of 1992
Certifications & Licensure
PA State Medical License 2002 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
Publications & Presentations
PubMed
- Accuracy of Ultrasound-Guided Attenuation Parameter for Diagnosing Hepatic Steatosis.Shiva D Yagobian, Navya Dasyam, Marta Minervini, Mitchell Tublin, Jaideep Behari
Ultrasound Quarterly. 2025-03-01 - What hepatology clinicians and their patients with alcohol-related liver disease think of wearable alcohol biosensors to aid abstinence from alcohol: A qualitative study.Andrea DiMartini, Jaideep Behari, Jon Punzi, Michael Dunn, Ramon Bataller
Drug and Alcohol Review. 2025-02-01 - 1 citationsAcute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.Ashok Choudhury, Anand V Kulkarni, Vinod Arora, A S Soin, Abdul Kadir Dokmeci
Hepatology International. 2025-02-01
Press Mentions
NIH Awards Grants for Using Bioengineered Models to Improve Clinical Trial DesignSeptember 30th, 2020
30% of Americans Have This Obesity-Related DiseaseMay 2nd, 2017- 9 Science-Backed Weight Loss TipsMay 26th, 2017
- Join now to see all
Grant Support
- Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health OutcomesUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2026
- Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health OutcomesUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2026
- Differential risk factors for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease (MASLD) patients of native Hawaiians compared with US whitesUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2026
- A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver diseaseUNIVERSITY OF PITTSBURGH AT PITTSBURGH2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
